It needs to redeem itself, 2017 has put a huge sta
Post# of 15624
There are few things that are still in the back of my mind as something we should be seeing, like, Gary keeps saying:
* Why isn't it in clinical database? Is it really that hard to do?
or, I know this may have IP consequences, but where are some kind of publications as to their trial results? Will we be seeing them? Is it too soon?
They will not get new investors, if all we'll get from them is just 8-K's without any scientific evidence, publications, website updates to keep potential and existing shareholders at bay, we'll hoover around where we are now, dwindling existing shareholders while waiting for takeover, buyout or whatever their plan is.
By the time it happens, most of us will exit, some will ride it out and others partially, it may or may not happen, but OWCP is now "Lets see and wait" stock as it carries a lot of baggage, for existing and potential investors, expect little to no movement until they prove themselves, and if I was on the sidelines, I'd would do just that.
I'm betting on some movement closer to completion of Phase 2, before then little will happen and we'll just channel without as lodge said, some resistance breaking, thanks to Ziv and Jeff for their fuckery.
Go $ODUB!